WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009067546) LUNG CANCER MARKERS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/067546    International Application No.:    PCT/US2008/084077
Publication Date: 28.05.2009 International Filing Date: 19.11.2008
IPC:
C12Q 1/68 (2006.01), G01N 33/574 (2006.01)
Applicants: CELERA CORPRATION [US/US]; c/o Celera Corporatiion 1401 Harbor Bay Parkway Alameda, California 94502 (US) (For All Designated States Except US).
BIRSE, Charles [GB/US]; (US) (For US Only).
RUBEN, Steve [US/US]; (US) (For US Only).
LEWIS, Marcia [CA/US]; (US) (For US Only).
MESRI, Mehdi [US/US]; (US) (For US Only)
Inventors: BIRSE, Charles; (US).
RUBEN, Steve; (US).
LEWIS, Marcia; (US).
MESRI, Mehdi; (US)
Agent: LEE, Victor K.; c/o Celera Corporation 1401 Harbor Bay Parkway Alameda, California 94502 (US)
Priority Data:
61/003,767 19.11.2007 US
Title (EN) LUNG CANCER MARKERS AND USES THEREOF
(FR) MARQUEURS DE CANCER DU POUMON ET LEURS UTILISATIONS
Abstract: front page image
(EN)Methods and compositions are provided for assessing (e.g., diagnosing), treating, and preventing diseases, especially cancer, and particular lung cancer, using lung cancer markers (LCM). Individual LCM and panels comprising multiple LCM are provided for these and other uses. Methods and compositions are also provided for determining or predicting the effectiveness of a treatment or for selecting a treatment using LCM. Methods and compositions are further provided for modulating cell function using LCM. Also provided are compositions that modulate LCM (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate LCM, and agents identified by these screening methods.
(FR)L'invention concerne des procédés et des compositions pour évaluer (par exemple, diagnostiquer), traiter et prévenir des maladies, en particulier un cancer, et plus spécifiquement un cancer du poumon, en utilisant des marqueurs de cancer du poumon (MCP). Elle concerne un MCP individuel et des batteries comprenant de multiples MCP à cet usage et d'autres. Elle concerne également des procédés et des compositions permettant de déterminer ou de prédire l'efficacité d'un traitement ou de choisir un traitement en utilisant un MCP. Elle concerne aussi des procédés et des compositions pour moduler la fonction cellulaire en utilisant un MCP. Elle concerne encore des compositions qui modulent un MCP (par exemple, antagonistes ou agonistes), telles que des anticorps, des protéines, des composés à petite molécule, et des agents de type acide nucléique (par exemple ARNi et agents antisens), ainsi que des compositions pharmaceutiques les contenant. Elle concerne enfin des procédés de criblage qui modulent les MCP, et des agents identifiés par ces procédés de criblage.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)